Cargando…

PET metabolic tumor volume as a new prognostic factor in childhood rhabdomyosarcoma

PURPOSE: Childhood RMS is a rare malignant disease in which evaluation of tumour spread at diagnosis is essential for therapeutic management. F-18 FDG-PET imaging is currently used for initial RMS disease staging. MATERIALS AND METHODS: This multicentre retrospective study in six French university h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fayolle, Helio, Jehanno, Nina, Lauwers-Cances, Valerie, Castex, Marie-Pierre, Orbach, Daniel, Mognetti, Thomas, Nadège, Corradini, Payoux, Pierre, Hitzel, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759649/ https://www.ncbi.nlm.nih.gov/pubmed/35030176 http://dx.doi.org/10.1371/journal.pone.0261565

Ejemplares similares

An emerging evidence base for PET-CT in the management of childhood rhabdomyosarcoma: systematic review
por: Norman, Gill, et al.
Publicado: (2015)

Locoregional Control and Survival in Children, Adolescents, and Young Adults With Localized Head and Neck Alveolar Rhabdomyosarcoma—The French Experience
por: Machavoine, Roxane, et al.
Publicado: (2022)

Cortical florbetapir-PET amyloid load in prodromal Alzheimer’s disease patients
por: Saint-Aubert, Laure, et al.
Publicado: (2013)

Pharmacological Characterization of [(18)F]-FNM and Evaluation of NMDA Receptors Activation in a Rat Brain Injury Model
por: Beaurain, Marie, et al.
Publicado: (2023)

Conservative management of a perianal rhabdomyosarcoma in a 2-year old child by Papillon’s technique
por: Demoor-Goldschmidt, Charlotte, et al.
Publicado: (2015)

Evaluation of functional and metabolic tumor volume using voxel-wise analysis in childhood rhabdomyosarcoma
por: Maennlin, Simon, et al.
Publicado: (2022)

Is surveillance imaging in pediatric patients treated for localized rhabdomyosarcoma useful? The European experience
por: Vaarwerk, Bas, et al.
Publicado: (2019)

Evaluation of desmin as a diagnostic and prognostic marker of childhood rhabdomyosarcomas and embryonal sarcomas.
por: Dias, P., et al.
Publicado: (1987)

High-dose chemotherapy followed by whole lung irradiation in pulmonary relapse Ewing’s sarcomas: a retrospective multicenter study
por: Duverge, Loig, et al.
Publicado: (2022)

Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee
por: Butel, Thibault, et al.
Publicado: (2020)

Imaging findings in noncraniofacial childhood rhabdomyosarcoma
por: Van Rijn, Rick R., et al.
Publicado: (2008)

Imaging findings in craniofacial childhood rhabdomyosarcoma
por: Freling, Nicole J. M., et al.
Publicado: (2010)

Maintenance Chemotherapy for Patients with Rhabdomyosarcoma
por: Bisogno, Gianni, et al.
Publicado: (2023)

Randomised clinical trial for the cost–utility evaluation of two strategies of perineal reconstruction after abdominoperineal resection in the context of anorectal carcinoma: biological mesh repair versus primary perineal wound closure, study protocol for the GRECCAR 9 Study
por: Buscail, Etienne, et al.
Publicado: (2021)

Presentation, Prognostic Factors and Patterns of Failure in Adult Rhabdomyosarcoma
por: Simon, James H., et al.
Publicado: (2003)

Clinical heterogeneity of neuro-inflammatory PET profiles in early Alzheimer’s disease
por: Gouilly, Dominique, et al.
Publicado: (2023)

Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database
por: Ben Bouallègue, Fayçal, et al.
Publicado: (2017)

Staging and monitoring of childhood rhabdomyosarcoma with flow cytometry
por: SHEN, HONGQIANG, et al.
Publicado: (2014)

Early Life Factors and Risk of Childhood Rhabdomyosarcoma
por: Shrestha, Anshu, et al.
Publicado: (2013)

Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)
por: Ferrari, Andrea, et al.
Publicado: (2022)

Local staging and treatment in extremity rhabdomyosarcoma. A report from the EpSSG‐RMS2005 study
por: Terwisscha van Scheltinga, Sheila E. J., et al.
Publicado: (2020)

Childhood rhabdomyosarcoma: experience of the Children's Solid Tumour Group.
por: Kingston, J. E., et al.
Publicado: (1983)

Identification of clinically achievable combination therapies in childhood rhabdomyosarcoma
por: Kahen, Elliot, et al.
Publicado: (2016)

8th conference on Finite Volumes for Complex Applications
por: Cancès, Clément, et al.
Publicado: (2017)

How to deal with the Poisson-gamma model to forecast patients' recruitment in clinical trials when there are pauses in recruitment dynamic?
por: Minois, Nathan, et al.
Publicado: (2017)

Therapy response evaluation with FDG-PET/CT in small cell lung cancer: a prognostic and comparison study of the PERCIST and EORTC criteria
por: Ziai, D., et al.
Publicado: (2013)

Alveolar rhabdomyosarcoma confined to the bone marrow with no identifiable primary tumour using FDG-PET/CT
por: Karagiannis, Panagiotis, et al.
Publicado: (2015)

Bladder and kidney function after cure of pelvic rhabdomyosarcoma in childhood.
por: Yeung, C. K., et al.
Publicado: (1994)

Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype
por: Ognjanovic, S, et al.
Publicado: (2010)

Posterior Cortical Atrophy: Does Complaint Match the Impairment? A Neuropsychological and FDG-PET Study
por: Guerrier, Laura, et al.
Publicado: (2019)

PET/CT imaging in management of concomitant Hodgkin lymphoma and tuberculosis – a problem solver tool
por: Jehanno, Nina, et al.
Publicado: (2017)

Sporadic and Familial Variants in NF1: An Explanation of the Wide Variability in Neurocognitive Phenotype?
por: Biotteau, Maëlle, et al.
Publicado: (2020)

Survival stratification in childhood rhabdomyosarcoma of the extremities: a derivation and validation study
por: Zhu, Linchao, et al.
Publicado: (2020)

Seasonality of main childhood embryonal tumours and rhabdomyosarcoma, France, 2000–2015
por: Awounou, Danielle, et al.
Publicado: (2023)

(11)C-Methionine PET/CT and (18)F-FDG PET/CT in the Evaluation of Adult Alveolar Rhabdomyosarcoma
por: Hiroshima, Yuka, et al.
Publicado: (2023)

PPAR Gamma and Viral Infections of the Brain
por: Layrolle, Pierre, et al.
Publicado: (2021)

Message in a Scaffold: Natural Biomaterials for Three-Dimensional (3D) Bioprinting of Human Brain Organoids
por: Layrolle, Pierre, et al.
Publicado: (2022)

Prognostic Significance of Volume-Based PET Parameters in Cancer Patients
por: Moon, Seung Hwan, et al.
Publicado: (2013)

Medical and pharmacological approach to adjust the salbutamol anti-doping policy in athletes
por: Pillard, Fabien, et al.
Publicado: (2015)

Expression of CD44 by rhabdomyosarcoma: a new prognostic marker?
por: Humphrey, G, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_aokcu2kkpqjqj2sae80mbiknql